Biogened Crescita futura
Future criteri di controllo 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Biogened.
Informazioni chiave
n/a
Tasso di crescita degli utili
n/a
Tasso di crescita dell'EPS
Pharmaceuticals crescita degli utili | 15.4% |
Tasso di crescita dei ricavi | n/a |
Rendimento futuro del capitale proprio | n/a |
Copertura analitica | None |
Ultimo aggiornamento | n/a |
Aggiornamenti recenti sulla crescita futura
Nessun aggiornamento
Recent updates
A Piece Of The Puzzle Missing From Biogened S.A.'s (WSE:BGD) 25% Share Price Climb
Aug 28Impressive Earnings May Not Tell The Whole Story For Biogened (WSE:BGD)
Aug 22Investors Give Biogened S.A. (WSE:BGD) Shares A 37% Hiding
May 23Here's Why Biogened (WSE:BGD) Has A Meaningful Debt Burden
May 09Biogened's (WSE:BGD) Promising Earnings May Rest On Soft Foundations
Feb 21Is Biogened (WSE:BGD) A Risky Investment?
Feb 01Biogened S.A. (WSE:BGD) Looks Just Right With A 37% Price Jump
Feb 01We Think Biogened (WSE:BGD) Can Stay On Top Of Its Debt
Jun 30Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly
Oct 08Is Biogened (WSE:BGD) A Risky Investment?
Jun 29Does Biogened (WSE:BGD) Have A Healthy Balance Sheet?
Mar 25These 4 Measures Indicate That Biogened (WSE:BGD) Is Using Debt Reasonably Well
Dec 09Biogened (WSE:BGD) Has A Somewhat Strained Balance Sheet
Jul 29Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly
Apr 30Is Biogened (WSE:BGD) A Risky Investment?
Jan 24In questa sezione di solito presentiamo le proiezioni di crescita dei ricavi e degli utili basate sulle stime di consenso degli analisti professionisti per aiutare gli investitori a capire la capacità della società di generare profitti. Tuttavia, poiché Biogened non ha fornito dati sufficienti sul passato e non ha previsioni degli analisti, i suoi utili futuri non possono essere calcolati in modo affidabile estrapolando i dati passati o utilizzando le previsioni degli analisti.
Si tratta di una situazione piuttosto rara, dato che il 97% delle società coperte da SimplyWall St dispone di dati finanziari passati.
Previsioni di crescita degli utili e dei ricavi
Data | Ricavi | Guadagni | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
---|---|---|---|---|---|
6/30/2024 | 106 | 5 | 4 | 12 | N/A |
3/31/2024 | 100 | 4 | 3 | 11 | N/A |
12/31/2023 | 96 | 5 | 8 | 15 | N/A |
9/30/2023 | 92 | 4 | 7 | 17 | N/A |
6/30/2023 | 90 | 4 | -2 | 9 | N/A |
3/31/2023 | 85 | 4 | -3 | 6 | N/A |
12/31/2022 | 80 | 3 | -3 | 6 | N/A |
9/30/2022 | 77 | 4 | -5 | -1 | N/A |
6/30/2022 | 72 | 4 | 0 | 2 | N/A |
3/31/2022 | 70 | 3 | 4 | 8 | N/A |
12/31/2021 | 65 | 2 | 2 | 3 | N/A |
9/30/2021 | 57 | 2 | 3 | 7 | N/A |
6/30/2021 | 54 | 2 | 4 | 7 | N/A |
3/31/2021 | 50 | 1 | 6 | 7 | N/A |
12/31/2020 | 48 | 1 | 7 | 9 | N/A |
9/30/2020 | 49 | 2 | 6 | 9 | N/A |
6/30/2020 | 48 | 1 | 5 | 8 | N/A |
3/31/2020 | 48 | 1 | 2 | 7 | N/A |
12/31/2019 | 47 | 1 | 2 | 6 | N/A |
9/30/2019 | 45 | 1 | -2 | 5 | N/A |
6/30/2019 | 44 | 1 | -2 | 4 | N/A |
3/31/2019 | 41 | 1 | -1 | 3 | N/A |
12/31/2018 | 40 | 1 | -1 | 4 | N/A |
9/30/2018 | 39 | 1 | 2 | 6 | N/A |
6/30/2018 | 39 | 1 | 0 | 4 | N/A |
3/31/2018 | 36 | 1 | N/A | 6 | N/A |
12/31/2017 | 34 | 1 | N/A | 6 | N/A |
9/30/2017 | 30 | 1 | N/A | 3 | N/A |
6/30/2017 | 31 | 1 | N/A | 4 | N/A |
3/31/2017 | 29 | 1 | N/A | 0 | N/A |
12/31/2016 | 29 | 1 | N/A | -1 | N/A |
9/30/2016 | 32 | 2 | N/A | -4 | N/A |
6/30/2016 | 31 | 2 | N/A | -5 | N/A |
3/31/2016 | 31 | 3 | N/A | -4 | N/A |
12/31/2015 | 30 | 3 | N/A | 0 | N/A |
9/30/2015 | 30 | 2 | N/A | 1 | N/A |
6/30/2015 | 26 | 1 | N/A | 2 | N/A |
3/31/2015 | 24 | 1 | N/A | 4 | N/A |
12/31/2014 | 23 | 1 | N/A | 1 | N/A |
9/30/2014 | 20 | 1 | N/A | 0 | N/A |
6/30/2014 | 21 | 1 | N/A | -2 | N/A |
3/31/2014 | 22 | 1 | N/A | -4 | N/A |
12/31/2013 | 22 | 2 | N/A | -4 | N/A |
Previsioni di crescita futura degli analisti
Guadagni vs tasso di risparmio: Insufficient data to determine if BGD's forecast earnings growth is above the savings rate (3.9%).
Guadagni vs Mercato: Insufficient data to determine if BGD's earnings are forecast to grow faster than the Polish market
Guadagni ad alta crescita: Insufficient data to determine if BGD's earnings are expected to grow significantly over the next 3 years.
Ricavi vs Mercato: Insufficient data to determine if BGD's revenue is forecast to grow faster than the Polish market.
Ricavi ad alta crescita: Insufficient data to determine if BGD's revenue is forecast to grow faster than 20% per year.
Previsioni di crescita dell'utile per azione
Rendimento futuro del capitale proprio
ROE futuro: Insufficient data to determine if BGD's Return on Equity is forecast to be high in 3 years time